We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments

News   Jul 30, 2015

 
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
 
 
Advertisement
 

RELATED ARTICLES

University of New Hampshire Awarded $1.8 M To Explore Drug Interactions and Targeted Drug Development

News

The University of New Hampshire is set to receive $1.8 million from the National Institutes of Health. This will be used to further the university's research to better understand drug interactions at the cellular level and help develop new targeted drugs to treat disorders including diabetes and cancer.

READ MORE

Circular RNA Molecule ciRS-7 Not Found in Cancer Cells After All

News

A new research result from Aarhus University shows that a circular RNA molecule, which has been designated as carcinogenic, is actually not found in the cancer cells. Researchers suggest that the molecule contributes to the cancer developing through what is known as the microenvironment.

READ MORE

SARS-CoV-2 Interactome Reveals Likely Molecular Mechanisms of Pathogenesis

News

University of Alabama at Birmingham researchers, led by Shahid Mukhtar, Ph.D., associate professor of biology in the UAB College of Arts and Sciences, have now built an interactome that includes the lung-epithelial cell host interactome integrated with a SARS-CoV-2 interactome.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE